-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the official website of the State Food and Drug Administration showed that the concentrated solution of sodium valproate for injection was approved by Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, and Chengdu Lier Pharmaceutical on the same day.
As of now, there are 7 companies of this product.
The company has production approvals, all of which have been reviewed
.
According to data from Minet.
com, in 2021, the sales of sodium valproate injection in China's public medical institutions will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%
.
As of now, there are 7 companies of this product.
The company has production approvals, all of which have been reviewed
.
According to data from Minet.
com, in 2021, the sales of sodium valproate injection in China's public medical institutions will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%
.
April 29, 2022 Information release of drug approval certificate pending collection
Data show that sodium valproate injection concentrate is used for the treatment of epilepsy, in adults and children , when the oral dosage form cannot be taken temporarily, it is used to replace the oral dosage form
.
.
Sales of terminal sodium valproate injection in Chinese public medical institutions in recent years (unit: 100 million yuan)
Source: Minet.
com China's public medical institutions terminal competition pattern
com China's public medical institutions terminal competition pattern
The latest data from Minet.
com shows that in 2021, the sales of terminal sodium valproate injection in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%.
Among them, Sanofi has the largest market share, followed by Shenyang Xinma Pharmaceutical
.
com shows that in 2021, the sales of terminal sodium valproate injection in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%.
Among them, Sanofi has the largest market share, followed by Shenyang Xinma Pharmaceutical
.
Sodium valproate injection products include sodium valproate for injection and sodium valproate concentrated solution for injection.
Among them, the concentrated solution of sodium valproate for injection includes Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, Chengdu Lier Pharmaceutical , Sichuan Keruid Pharmaceutical and other 7 companies have production approval documents, all of which have been approved for production in the third category of imitation, which are regarded as over-evaluation
.
Among them, the concentrated solution of sodium valproate for injection includes Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, Chengdu Lier Pharmaceutical , Sichuan Keruid Pharmaceutical and other 7 companies have production approval documents, all of which have been approved for production in the third category of imitation, which are regarded as over-evaluation
.
Sodium valproate injection concentrated solution under review
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
At present, 8 companies including Hainan Better Pharmaceutical, Jichuan Pharmaceutical Group and Jiangxi Qingfeng Pharmaceutical have applied for production of concentrated solution of sodium valproate for injection
.
.
Source: State Food and Drug Administration official website, Minet database
A few days ago, the official website of the State Food and Drug Administration showed that the concentrated solution of sodium valproate for injection was approved by Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, and Chengdu Lier Pharmaceutical on the same day.
As of now, there are 7 companies of this product.
The company has production approvals, all of which have been reviewed
.
According to data from Minet.
com, in 2021, the sales of sodium valproate injection in China's public medical institutions will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%
.
As of now, there are 7 companies of this product.
The company has production approvals, all of which have been reviewed
.
According to data from Minet.
com, in 2021, the sales of sodium valproate injection in China's public medical institutions will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%
.
April 29, 2022 Information release of drug approval certificate pending collection
Data show that sodium valproate injection concentrate is used for the treatment of epilepsy, in adults and children , when the oral dosage form cannot be taken temporarily, it is used to replace the oral dosage form
.
.
Sales of terminal sodium valproate injection in Chinese public medical institutions in recent years (unit: 100 million yuan)
Source: Minet.
com China's public medical institutions terminal competition pattern
com China's public medical institutions terminal competition pattern
The latest data from Minet.
com shows that in 2021, the sales of terminal sodium valproate injection in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%.
Among them, Sanofi has the largest market share, followed by Shenyang Xinma Pharmaceutical
.
com shows that in 2021, the sales of terminal sodium valproate injection in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%.
Among them, Sanofi has the largest market share, followed by Shenyang Xinma Pharmaceutical
.
Sodium valproate injection products include sodium valproate for injection and sodium valproate concentrated solution for injection.
Among them, the concentrated solution of sodium valproate for injection includes Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, Chengdu Lier Pharmaceutical , Sichuan Keruid Pharmaceutical and other 7 companies have production approval documents, all of which have been approved for production in the third category of imitation, which are regarded as over-evaluation
.
Among them, the concentrated solution of sodium valproate for injection includes Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, Chengdu Lier Pharmaceutical , Sichuan Keruid Pharmaceutical and other 7 companies have production approval documents, all of which have been approved for production in the third category of imitation, which are regarded as over-evaluation
.
Sodium valproate injection concentrated solution under review
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
At present, 8 companies including Hainan Better Pharmaceutical, Jichuan Pharmaceutical Group and Jiangxi Qingfeng Pharmaceutical have applied for production of concentrated solution of sodium valproate for injection
.
.
Source: State Food and Drug Administration official website, Minet database
A few days ago, the official website of the State Food and Drug Administration showed that the concentrated solution of sodium valproate for injection was approved by Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, and Chengdu Lier Pharmaceutical on the same day.
As of now, there are 7 companies of this product.
The company has production approvals, all of which have been reviewed
.
According to data from Minet.
com, in 2021, the sales of sodium valproate injection in China's public medical institutions will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%
.
As of now, there are 7 companies of this product.
The company has production approvals, all of which have been reviewed
.
According to data from Minet.
com, in 2021, the sales of sodium valproate injection in China's public medical institutions will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%
.
April 29, 2022 Information release of drug approval certificate pending collection
Data show that sodium valproate injection concentrate is used for the treatment of epilepsy, in adults and children , when the oral dosage form cannot be taken temporarily, it is used to replace the oral dosage form
.
children children children.
Sales of terminal sodium valproate injection in Chinese public medical institutions in recent years (unit: 100 million yuan)
Source: Minet.
com China's public medical institutions terminal competition pattern
com China's public medical institutions terminal competition pattern
The latest data from Minet.
com shows that in 2021, the sales of terminal sodium valproate injection in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%.
Among them, Sanofi has the largest market share, followed by Shenyang Xinma Pharmaceutical
.
hospital hospital hospitalcom shows that in 2021, the sales of terminal sodium valproate injection in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) will exceed 1.
5 billion yuan, a year-on-year increase of 12.
23%.
Among them, Sanofi has the largest market share, followed by Shenyang Xinma Pharmaceutical
.
Sodium valproate injection products include sodium valproate for injection and sodium valproate concentrated solution for injection.
Among them, the concentrated solution of sodium valproate for injection includes Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, Chengdu Lier Pharmaceutical , Sichuan Keruid Pharmaceutical and other 7 companies have production approval documents, all of which have been approved for production in the third category of imitation, which are regarded as over-evaluation
.
enterprise enterprise enterpriseAmong them, the concentrated solution of sodium valproate for injection includes Chengdu Yuandong Biopharmaceutical, Sichuan Huiyu Pharmaceutical, Chengdu Lier Pharmaceutical , Sichuan Keruid Pharmaceutical and other 7 companies have production approval documents, all of which have been approved for production in the third category of imitation, which are regarded as over-evaluation
.
Sodium valproate injection concentrated solution under review
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
At present, 8 companies including Hainan Better Pharmaceutical, Jichuan Pharmaceutical Group and Jiangxi Qingfeng Pharmaceutical have applied for production of concentrated solution of sodium valproate for injection
.
.
Source: State Food and Drug Administration official website, Minet database
